EMGA obtient un financement par emprunt de 20 millions de dollars US pour Banco Improsa du Costa Rica

LONDRES, 01 nov. 2022 (GLOBE NEWSWIRE) — Emerging Markets Global Advisory LLP (EMGA), qui travaille pour la deuxième fois avec Banco Improsa, obtient cette facilité de 20 millions de dollars US auprès de l’Agence espagnole de coopération internationale pour le développement (AECID)- AECID (conseillée par la COFIDES).

Commentant cette transaction, Felix Alpizar, directeur général de BANCO IMPROSA, a déclaré : « Banco Improsa est très honoré d’être reconnu par l’AECID et la COFIDES pour ses antécédents et pour ses programmes visant à financer et à soutenir les micro, petites et moyennes entreprises (MPME) costariciennes. Grâce à cette facilité de crédit, nous poursuivrons notre contribution au développement économique et social du pays. »

Sajeev Chakkalakal, directeur de la banque d’investissement d’EMGA, a déclaré : « Nous sommes de nouveau ravis de contribuer à la vision continue de Banco Improsa de soutenir les PME au Costa Rica et de compléter cette solution de financement avec l’AECID (conseillée par la COFIDES). »

José Luis Curbelo, président-directeur général de COFIDES, a déclaré : « Nous sommes très heureux de soutenir l’AECID dans son premier projet d’impact avec EMGA et BANCO IMPROSA dans la région d’Amérique centrale. La transaction servira à financer les petites et moyennes entreprises au Costa Rica, ce qui contribuera à la création et au maintien d’emplois de qualité et à la réduction des inégalités. Nous sommes impatients de poursuivre ces partenariats stratégiques qui améliorent la croissance économique dans les pays en développement en renforçant le secteur privé grâce à un soutien financier solide. »

Carlos Jiménez Aguirre, directeur général du FONPRODE et chef du département de coopération financière de l’AECID, a déclaré que « la formalisation de cette transaction reflète les objectifs de la coopération espagnole de contribuer à élargir le soutien financier aux micro, petites et moyennes entreprises (MPME) costariciennes, car les MPME jouent un rôle clé dans la création et le maintien d’emplois décents et la réduction des inégalités. Notre intention est d’étendre ce type de soutien à d’autres pays d’Amérique centrale en leur donnant accès au financement des MPME, avec un accent particulier mis sur l’intégration des stratégies relatives à l’égalité des sexes et aux changements climatiques dans les activités du secteur privé. »

Emerging Markets Global Advisory LLP, basée à Londres, aide les institutions financières et les entreprises basées sur les marchés émergents, qui recherchent de nouveaux capitaux d’emprunt ou capitaux propres.

Banco Improsa a été fondée en 1995. C’est une banque de niche spécialisée dans la fourniture de solutions et de services financiers aux MPME, qui représentent la majeure partie de son portefeuille. Elle dispose d’une vaste expérience dans la fourniture de services de soutien et de conseils aux MPME. Le facteur clé de réussite de Banco Improsa réside dans son engagement envers des normes élevées de service personnalisé, agile et flexible, qui, avec des solutions financières personnalisées, lui ont permis d’atteindre une position solide dans ces segments. Banco Improsa fait partie de Grupo Financiero Improsa (GFI).

Le Fonds pour la promotion du développement (FONPRODE) est géré par l’Agence espagnole pour la Coopération internationale au développement (AECID) avec l’appui de la COFIDES (Institution espagnole de financement du développement). L’AECID est le principal organe de gestion de la coopération espagnole et est axée sur la lutte contre la pauvreté et la promotion du développement durable. La COFIDES fournit un soutien à la gestion du FONPRODE avec des opérations de financement remboursables qui favorisent le développement économique et social des pays partenaires par le biais d’investissements ou de transferts de ressources économiques à caractère remboursable. Le FONPRODE peut financer des dettes et des capitaux propres non remboursables et remboursables. Parmi les exemples de financement remboursable proposés par le FONPRODE, on peut citer les prêts aux prestataires de services financiers visant à l’inclusion financière.

La COFIDES, société publique qui se consacre à la gestion de l’État et de tiers, ainsi que de ses propres fonds, poursuit plusieurs objectifs : l’internationalisation de l’économie espagnole, la promotion du développement économique et la fortification de la solvabilité des sociétés touchées par la COVID-19. Outre l’État espagnol, ses actionnaires comprennent Banco Santander, Banco Bilbao Vizcaya Argentaria (BBVA), Banco Sabadell et la Banque de développement d’Amérique latine (CAF).

Dobson Jeremy

info@emergingmarketsglobaladvisory.com

GlobeNewswire Distribution ID 1000754205

EMGA garante financiamento de 20M USD para Banco Improsa da Costa Rica

LONDRES, Nov. 01, 2022 (GLOBE NEWSWIRE) — A Emerging Markets Global Advisory LLP (EMGA), pela segunda vez a trabalhar com o Banco Improsa, assegura uma linha de crédito de 20 milhões de dólares da Agência Espanhola de Cooperação Internacional para o Desenvolvimento – AECID (assessorada pela COFIDES).

Comentando a transação, Felix Alpizar, Diretor-geral do Banco Improsa, afirmou: “O Banco Improsa sente-se honrado por ser reconhecido pela AECID e COFIDES pelo seu historial e programas de financiamento e apoio às micro, pequenas e médias empresas costa-riquenhas (MPME). Com esta linha de crédito, continuaremos a contribuir para o desenvolvimento económico e social do país.”

Sajeev Chakkalakal, Diretor de Banca de Investimentos da EMGA, disse: “É um prazer, mais uma vez, poder apoiar a visão continuada do Banco Improsa, de apoiar as PME na Costa Rica, e fechar este acordo de financiamento com a AECID (assessorada pela COFIDES).”

José Luis Curbelo, Presidente e Diretor-executivo da COFIDES, declarou que “temos o prazer de apoiar a AECID no seu primeiro projeto de grande impacto com a EMGA e o Improsa na região da América Central. Esta transação servirá para financiar pequenas e médias empresas na Costa Rica, o que contribuirá para a criação e manutenção de empregos de qualidade e para a redução das desigualdades. Esperamos poder continuar com estas parcerias estratégicas, que aumentam o crescimento económico nos países em desenvolvimento através do reforço do setor privado com um apoio financeiro sólido.”

Carlos Jiménez Aguirre, Diretor-geral da FONPRODE e Diretor do Departamento de Cooperação Financeira da AECID indicou que “a formalização desta transação reflete os objetivos da Cooperação Espanhola de contribuir para expandir o apoio financeiro às micro, pequenas e médias empresas (MPME) da Costa Rica, uma vez que as MPME desempenham um papel fundamental na criação e manutenção de empregos decentes e na redução de desigualdades. A nossa intenção é expandir este tipo de apoio a outros países da América Central, facilitando o acesso das MPME ao financiamento, com especial atenção à integração das estratégias de género e das alterações climáticas nas atividades do setor privado.”

A Emerging Markets Global Advisory LLP, com sede em Londres, ajuda empresas e instituições financeiras de mercados emergentes a obterem novas linhas de crédito ou a reforçar os seus capitais próprios.

O Banco Improsa foi fundado em 1995 e é um banco de nicho de mercado especializado na prestação de serviços financeiros e fornecimento de soluções financeiras às MPME, as quais representam a maior parte da sua carteira de clientes. O banco tem um vasto historial na prestação de serviços de apoio e aconselhamento às MPME. A chave para o sucesso do Banco Improsa reside no seu compromisso com elevados padrões de serviço personalizado, ágil e flexível, que, juntamente com soluções financeiras personalizadas, lhe tem permitido alcançar uma posição sólida nestes segmentos. O Banco Improsa faz parte do Grupo Financiero Improsa (GFI).

O Fundo para a Promoção do Desenvolvimento (FONPRODE) é gerido pela Agência Espanhola de Cooperação Internacional para o Desenvolvimento (AECID) com o apoio da COFIDES (Instituição Financeira Espanhola para o Desenvolvimento). A AECID é o principal organismo de gestão da Cooperação Espanhola e está orientada para a luta contra a pobreza e a promoção do desenvolvimento sustentável. A COFIDES fornece assessoria à gestão do FONPRODE com operações de financiamento reembolsáveis que promovem o desenvolvimento social e económico dos países parceiros através de investimentos ou transferências de recursos económicos com carácter reembolsável. O FONPRODE pode assegurar o financiamento não-reembolsável ou reembolsável de dívida e capitais próprios. Exemplos de financiamentos reembolsáveis no âmbito do FONPRODE são os empréstimos a prestadores de serviços financeiros destinados à inclusão financeira.

A COFIDES, uma empresa pública que se dedica à gestão de fundos públicos e de terceiros, bem como dos seus fundos próprios, persegue vários objetivos: internacionalização da economia espanhola, promoção do desenvolvimento económico e reforço da solvência das empresas afetadas pela COVID-19. Entre os seus acionistas contam-se, para além do Estado espanhol, o Banco Santander, o Banco Bilbao Vizcaya Argentaria (BBVA), o Banco Sabadell e o Banco de Desenvolvimento da América Latina (CAF).

Jeremy Dobson

info@emergingmarketsglobaladvisory.com

GlobeNewswire Distribution ID 1000754205

Hisense Launches New Soundbars and Party Speaker in South Africa, Bring Listening Experience to a New Level

CAPE TOWN, South Africa, Nov. 1, 2022 /PRNewswire/ — Hisense, a leading electronics manufacturer, announced that the company is bringing a new suite of offerings dedicated to elevating the listening experience to South Africa. The three products – HP100 Speaker for party music, Dolby Atmos® AX5100G and AX3100G Soundbar for theatre-level entertainment, are crafted with the purpose to deliver size-defying performance, packing sound-enhancing features that complement users’ home cinematic setups to create an immersive audio-visual experience

“Whether it is for a home movie night or an outdoor friend gathering, we hope to offer our customers a range of products with easy-to-use and powerful features that allow them to create immersive cinematic or musical experiences,” said Patrick, marketing director of Hisense South Africa.

The Hisense Party Rock Speaker HP100 has a trendy and eye-catching appearance with a sleek black finish and coloured light panels around its four speakers. With its powerful sound system and great versatility, HP100 is designed to level up the party experience with various cool features, including the Karaoke Mode, five lighting effects, and five DJ effects.

The HP100’s compact yet mighty sound powerhouse is fitted with two 6.5″ woofers and two 2.5″ tweeters, supercharged by its 300-watt power output, capable of delivering loud crisp sound and deep, pumping bass. Thanks to its 15 hours of battery life and an IPX4 splashproof design, HP100 allows the users to enjoy all-night fun with the dazzling light rims adding an electrifying effect to the music scene.

Users can take advantage of AX5100G’s 340-watt maximum power output to enjoy the room-filling immersion, along with the support for Dolby Atmos® and DTS: X® that can transform music, film or gaming content into a breathtakingly realistic surround auditory feast.

Both the AX5100G 5.1-channel and AX3100G 3.1-channel Soundbars feature seven speakers that transport the listener to the centre of the music or movie scene, as well as a powerful 6.5′′ wireless subwoofer that delivers rich and beefy bass, allowing users to enjoy exceptional detail and depth of their favourite tracks and shows. The two models are designed for greater simplicity and versatility, with a wall-mountable design and a wide choice of connectivity options that allow users to easily set up the device with simple installation steps.

Photo – https://mma.prnewswire.com/media/1934888/image_5020023_32572150.jpg

UN Peacekeepers in Congo Make ‘Strategic Withdrawal’ From Key Military Base

The United Nations peacekeeping mission in Democratic Republic of Congo on Tuesday said its troops had made a strategic withdrawal from the eastern military base of Rumangabo, ceding ground in the battle against the M23 rebel group.

U.N. troops have been supporting Congolese forces in the fight against the M23, which launched a new offensive in October and seized the town of Kiwanja last Saturday, breaking months of relative calm.

“We have made a strategic and tactical withdrawal from Rumangabo, in consultation with our partners, to better prepare the next steps together,” the U.N. mission, known as MONUSCO, said in a post on Twitter.

It did not provide further details.

The loss of the major military base is a setback for Congo and a further blow to the security outlook in the conflict-hit east. The crisis has also deepened a standoff with neighboring Rwanda over its alleged support for the rebels, which it denies.

“Its fall is another humiliation for Kinshasa. But it also raises serious questions, once again, of how an extremely small rebellion can do this on their own,” said Jason Stearns, founder of the Congo Studies Group, a research institute at New York University.

In August, U.N. experts said they had found solid evidence Rwanda had been interfering militarily in eastern Congo.

Rwanda’s government has disputed the findings.

Goma, the capital of Congo’s North-Kivu province, has been effectively cut off from the upper half of the province since the capture of Kiwanja. More than 90,000 people have fled their homes since fighting resumed on October 20, according to the U.N.

The escalation prompted East African heads of state to hold a joint call Tuesday and schedule a meeting of their defense chiefs to address the security crisis, the office of Burundi’s president said in a statement.

 

 

Source: Voice of America

Antibody Treatment Tested as New Tool Against Malaria

Research in Africa found a one-time dose of an experimental drug protected adults against malaria for at least six months, the latest approach in the fight against the mosquito-borne disease.

 

Malaria killed more than 620,000 people in 2020 and sickened 241 million, mainly children under 5 in Africa. The World Health Organization is rolling out the first authorized malaria vaccine for children, but it is about 30% effective and requires four doses.

 

The new study tested a very different approach — giving people a big dose of lab-made malaria-fighting antibodies instead of depending on the immune system to make enough of those same infection-blockers after vaccination.

 

“The available vaccine doesn’t protect enough people,” said Dr. Kassoum Kayentao of the University of Sciences, Techniques and Technologies in Bamako, Mali, who helped lead the study in the villages of Kalifabougou and Torodo.

In those villages during malaria season, other research has shown, people are bitten by infected mosquitoes on average twice a day.

 

The experimental antibody, developed by researchers at the U.S. National Institutes of Health, was given by IV — difficult to deliver on a large scale. But the encouraging findings bode well for an easier-to-administer shot version from the same scientists that’s in early testing in infants, children and adults.

 

The U.S. government research was published Monday in the New England Journal of Medicine and presented at a medical meeting in Seattle.

 

The antibody works by breaking the life cycle of the parasite, which is spread through mosquito bites. It targets immature parasites before they enter the liver where they can mature and multiply. It was developed from an antibody taken from a volunteer who received a malaria vaccine.

 

The research involved 330 adults in Mali who got either one of two different antibody doses or a dummy infusion. All were tested for malaria infection every two weeks for 24 weeks. Anyone who got sick was treated.

 

Infections were detected by blood test in 20 people who got the higher dose, 39 people who got the lower dose and 86 who got the placebo.

 

The higher dose was 88% effective, compared to the placebo. The lower dose was 75% effective.

 

Protection might last during the several months of a malaria season. The idea is to someday use it alongside other malaria prevention methods such as malaria pills, mosquito nets and vaccines. Cost is uncertain, but one estimate suggests lab-made antibodies could be given for as little as $5 per child per malaria season.

 

Lab-made antibodies are used to treat cancer, autoimmune diseases and COVID-19, said Dr. Johanna Daily of Albert Einstein College of Medicine in New York, who was not involved in the study.

 

“The good news is now we have another, immune-based therapy to try to control malaria,” Daily said.

 

 

 

Source: Voice of America